CYRX.NASDAQCryoport, INC

Form 4: Cryoport Director Ramkumar Mandalam Executes Stock Option and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Director Ramkumar Mandalam exercised stock options and sold shares of Cryoport, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On August 2, 2024, Ramkumar Mandalam, a director of Cryoport, Inc., exercised stock options to acquire 4,167 shares of common stock at a price of $5.04 per share.
  • Simultaneously, Mandalam sold 4,167 shares of common stock at a weighted average price of $8.0442 per share, with individual sales prices ranging from $7.80 to $8.29.
  • These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 15, 2024.
  • Following these transactions, Mandalam beneficially owns 56,032 shares of Cryoport, Inc. common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing reflects routine transactions under a pre-arranged trading plan. There's no indication of positive or negative sentiment towards the company's prospects.

Industry Context

This filing reflects routine transactions by a company insider under a pre-arranged trading plan, which is a common practice to avoid accusations of insider trading. It doesn't necessarily indicate a change in the director's confidence in the company's future prospects.

Key Dates

DateDescription
03/15/2024Date of adoption of Rule 10b5-1 trading plan
08/02/2024Date of stock option exercise and share sale
08/06/2024Date of Form 4 filing
08/29/2024Expiration date of stock options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.